To gain insights into potential mechanisms of the observed phenomenon, we compared the transcriptomic profiles of glioma-associated CD11b+ cells isolated from control mice (CTR), mice treated with anti-PD-1, OAT-1746 or a combination of both (COMB). The gene discussed is PDCD1; the disease is central nervous system cancer.